Immunoproliferative Disorders: 11806 Clinical Trials, Page 1 of 1181

1 2 3 4 5 10 15 20  Last Page »

Hide Studies Not Open or Pending

9

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Condition(s):Multiple Myeloma; Neoplasm, Plasma Cell; Neoplasms by Histologic Type; Neoplasms; Hemostatic Disorder; Vascular Diseases; Cardiovascular Diseases; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Hemorrhagic Disorders; Lymphoproliferative Disorders; Immunoproliferative Disorders; Immune System Diseases; Antineoplastic Agents; Analgesics, Non-Narcotic; Analgesics; Sensory System Agents; Peripheral Nervous System Agents; Physiological Effects of DrugsLast Updated:February 16, 2023Active, not recruiting

1 2 3 4 5 10 15 20  Last Page »

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.